Latest1 information on COVID-19

Clinical Trials Contact

About this Clinical Trial

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Your Message Will Go To

Sabrina Biedermann

(650) 498-6000


All fields are required. *

Preferred contact method*

To:

Sabrina Biedermann

(650) 498-6000



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine